Menthozen

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Menthozen
Generic name: METHYL SALICYLATE, MENTHOL, CAPSAICIN
Manufacturer: Village Pharma LLC
Product type: HUMAN OTC DRUG
SPL set ID: 48b1b99e-d0ec-4e5c-b80c-c0d2d87ecb13
SPL ID: 49124ae3-42ed-4a76-a091-ac46529ed235
Version: 4
Effective date: 2026-01-01
Source export date: 2026-10-12
Source partition: 8
Source file: https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/fa098e7c5cff0b1ab653ce934059d1f4b90b860bafc0383a1f66223ce1037518/drug-label-0008-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:14:34

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Menthozen	openfda.brand_name
generic name		METHYL SALICYLATE, MENTHOL, CAPSAICIN	openfda.generic_name
manufacturer name		Village Pharma LLC	openfda.manufacturer_name
ndc	package	71574-600-72	openfda.package_ndc
ndc	product	71574-600	openfda.product_ndc
ndc11	package	71574060072	derived:openfda.package_ndc
rxcui		1099896	openfda.rxcui
spl id		49124ae3-42ed-4a76-a091-ac46529ed235	id
spl set id		48b1b99e-d0ec-4e5c-b80c-c0d2d87ecb13	set_id
unii		S07O44R1ZM	openfda.unii
unii		L7T10EIP3A	openfda.unii
unii		LAV5U5022Y	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS: • For external use only. • Avoid contact with the eyes. • If condition worsens, or if symptoms persist for more than seven days or clear up and occur again with a few days, discontinue use of this product and consult a physician. Keep out of reach of children. If swallowed, consult physician. Do not apply • to wounds or damaged skin. • Do not bandage tightly. If pregnant or breast feeding, contact a physician prior to use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.